Hematopoietic stem cell transplantation and quality of life during the first year of treatment.
CONCLUSIONS: although the aggressiveness of treatment affects quality of life, patients consider it satisfactory after the first year. There are few significant differences between autologous and allogenic patients, and both groups have recovered in the course of the process.
PMID: 30379249 [PubMed - in process]
Source: Revista Latino-Americana de Enfermagem - Category: Nursing Authors: Marques ADCB, Szczepanik AP, Machado CAM, Santos PND, GuimarĂ£es PRB, Kalinke LP Tags: Rev Lat Am Enfermagem Source Type: research
More News: Bone Marrow Transplant | Brazil Health | Cancer | Cancer & Oncology | Cancer Therapy | Hematology | Leukemia | Pain | Pancytopenia | Portugal Health | Stem Cell Therapy | Stem Cells | Transplants